Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs

• by Kerry R. Love, Stacy E. Martin, Laura Crowell Orella

• May 18, 2026

Identification of clinical phenotypes and prediction model for the mixed-infection phenotype of pediatric community-acquired pneumonia based on unsupervised machine learning

• by Meng Xiao, Ying Jiang, Qiaobin Chen, Yongxi Deng, Hongbiao Huang, Qiong Fang, Xiaoting Lin, Lijun Xiong

• May 21, 2026

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.

• by Andrea Surnit

• May 13, 2026

• 4 min

Estimated pneumococcal disease burden in children due to serotypes covered by different pneumococcal conjugate vaccines in five Latin American countries

• by Sophie Warren, Rafael Bolanos, Lucila Rey-Ares, Juan Manuel Reyes, Jose Luis Huerta, Alana Ranzi, Rodrigo Fernandes Alexandre, Maria Gabriela Abalos, Liping Huang

• May 21, 2026